The gut-brain axis is a popular topic these days—and the subject of numerous webcasts. But one topic not often discussed is how clinical trials are being designed on the gut-brain axis.
Nutritional studies on the gut microbiome are increasingly of interest, particularly as they relate to mood disorders such as anxiety and depression as well as cognitive performance measures. In this webcast, we examine how gut-brain-axis clinical trials are being designed. Researchers interested in investigating the role of the gut microbiome in cognitive health disorders such as stress, mood, anxiety, depression, or cognitive performance measures like memory, attention, focus and alertness, you won’t want to miss this webcast.
Key Learning Objectives:
- Understand the role of the gut microbiome in cognitive function , including the microbial signatures for anxiety, depression, and mild cognitive impairment
- Hear expert opinion on the selection of study design–related parameters such as study population, sample size, effect size, duration of treatment, and outcome measures with the help of relevant case studies
- Learn about specific changes to microbiota and microbial biomarkers measured as part of microbiota-gut-brain-axis clinical trials
- Identify some of the key subjective measures (questionnaires and scales) of wellbeing used in these types of studies
Speaker: Miguel Toribio-Mateas, MSc, DProf (c), Clinical Neuroscientist and Nutrition Researcher, Atlas Biomed
Shalini Srivastava, MD, Director Clinical Development, Vedic Lifesciences
Time and Date: Tuesday, February 23, 2021 at 2pm EST | 1pm CST | 11am PST
On Demand Until Feb. 23, 2022.
Sponsors: Vedic Lifesciences